Eric Pauwels
CHIEF EXECUTIVE OFFICER at PTC Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: PTC Therapeutics Inc., 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | PTC Therapeutics Inc. | Open-market sale | โ3,711 | $75.00 | $278,325 |
| Jun 10, 2026 | PTC Therapeutics Inc. | Option exercise | +17,566 | $18.01 | $316,364 |
| Jun 10, 2026 | PTC Therapeutics Inc. | Open-market sale | โ17,566 | $75.00 | $1,317,450 |
| Feb 18, 2026 | PTC Therapeutics Inc. | Open-market sale | โ3,019 | $69.36 | $209,398 |
| Jan 12, 2026 | PTC Therapeutics Inc. | Open-market sale | โ1,024 | $78.70 | $80,589 |
| Jan 9, 2026 | PTC Therapeutics Inc. | Open-market sale | โ1,722 | $77.41 | $133,300 |
| Jan 8, 2026 | PTC Therapeutics Inc. | Open-market sale | โ2,561 | $76.42 | $195,712 |
| Jan 8, 2026 | PTC Therapeutics Inc. | Open-market sale | โ587 | $76.98 | $45,187 |
| Jan 8, 2026 | PTC Therapeutics Inc. | Open-market sale | โ1,454 | $76.45 | $111,158 |
| Jan 7, 2026 | PTC Therapeutics Inc. | Open-market sale | โ1,352 | $77.48 | $104,753 |
| Jan 6, 2026 | PTC Therapeutics Inc. | Open-market sale | โ1,789 | $76.95 | $137,664 |
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +20,000 | โ | โ |
| Dec 19, 2025 | PTC Therapeutics Inc. | Option exercise | +138 | $66.49 | $9,176 |
| Dec 19, 2025 | PTC Therapeutics Inc. | Open-market sale | โ37 | $75.66 | $2,799 |
| Dec 19, 2025 | PTC Therapeutics Inc. | Open-market sale | โ42 | $77.26 | $3,245 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.